Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH; Conference Participants.

J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. doi: 10.1016/j.jacc.2019.08.1017. Review.

2.

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ; Conference Participants.

Kidney Int. 2019 Oct;96(4):836-849. doi: 10.1016/j.kint.2019.06.025.

3.

Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction.

McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.

Kidney Int. 2019 Jun 11. pii: S0085-2538(19)30594-0. doi: 10.1016/j.kint.2019.05.019. [Epub ahead of print]

PMID:
31420191
4.

Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.

Ku E, Sarnak MJ, Toto R, McCulloch CE, Lin F, Smogorzewski M, Hsu CY.

J Am Heart Assoc. 2019 Aug 20;8(16):e012749. doi: 10.1161/JAHA.119.012749. Epub 2019 Aug 14.

5.

Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Drew DA, Weiner DE, Sarnak MJ.

Am J Kidney Dis. 2019 Aug 1. pii: S0272-6386(19)30828-5. doi: 10.1053/j.ajkd.2019.05.017. [Epub ahead of print] Review.

PMID:
31378643
6.

Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.

McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.

Am J Kidney Dis. 2019 Jul 11. pii: S0272-6386(19)30793-0. doi: 10.1053/j.ajkd.2019.05.010. [Epub ahead of print]

PMID:
31303349
7.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

Garimella PS, Lee AK, Ambrosius WT, Bhatt U, Cheung AK, Chonchol M, Craven T, Hawfield AT, Jotwani V, Killeen A, Punzi H, Sarnak MJ, Wall BM, Ix JH, Shlipak MG.

Eur Heart J. 2019 Jun 30. pii: ehz392. doi: 10.1093/eurheartj/ehz392. [Epub ahead of print]

PMID:
31257404
8.

More Evidence to Suggest a Relation of Blood Pressure to Long-term Progression of Kidney Disease: Is It Causal?

McCallum W, Ku E, Sarnak MJ.

Am J Kidney Dis. 2019 Sep;74(3):293-296. doi: 10.1053/j.ajkd.2019.05.004. Epub 2019 Jun 27. No abstract available.

PMID:
31257049
9.

Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure.

McCallum W, Tighiouart H, Kiernan MS, Huggins GS, Sarnak MJ.

Am J Med. 2019 Jun 24. pii: S0002-9343(19)30529-7. doi: 10.1016/j.amjmed.2019.05.047. [Epub ahead of print]

PMID:
31247182
10.

Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Am J Kidney Dis. 2019 Oct;74(4):501-509. doi: 10.1053/j.ajkd.2019.02.024. Epub 2019 May 22.

PMID:
31128770
11.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

12.

Blood Pressure and Cognitive Decline in Prevalent Hemodialysis Patients.

Drew DA, Tighiouart H, Duncan S, Rollins J, Gupta A, Scott T, Weiner DE, Sarnak MJ.

Am J Nephrol. 2019;49(6):460-469. doi: 10.1159/000500041. Epub 2019 May 2.

PMID:
31048586
13.

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE; Conference Participants.

Kidney Int. 2019 May;95(5):1027-1036. doi: 10.1016/j.kint.2018.12.025.

14.

The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease.

Rebholz CM, Surapaneni A, Levey AS, Sarnak MJ, Inker LA, Appel LJ, Coresh J, Grams ME.

J Nutr. 2019 Apr 1;149(4):578-585. doi: 10.1093/jn/nxy311.

PMID:
30919901
15.

Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Nephrol Dial Transplant. 2019 Mar 21. pii: gfz008. doi: 10.1093/ndt/gfz008. [Epub ahead of print]

PMID:
30903163
16.

Subclinical Cognitive Impairment and Listing for Kidney Transplantation.

Gupta A, Montgomery RN, Bedros V, Lesko J, Mahnken JD, Chakraborty S, Drew D, Klein JA, Thomas TS, Ilahe A, Budhiraja P, Brooks WM, Schmitt TM, Sarnak MJ, Burns JM, Cibrik DM.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):567-575. doi: 10.2215/CJN.11010918. Epub 2019 Mar 19.

PMID:
30890576
17.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Am J Clin Nutr. 2019 Mar 1;109(3):517-525. doi: 10.1093/ajcn/nqy202.

PMID:
30753252
18.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):342-353. doi: 10.2215/CJN.10010818. Epub 2019 Feb 7.

PMID:
30733224
19.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
20.

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625-637.

Chronic Kidney Disease Prognosis Consortium.

Kidney Int Rep. 2018 Aug 30;3(6):1506. doi: 10.1016/j.ekir.2018.08.009. eCollection 2018 Nov.

21.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
22.

Kidney Function and Hospital-Acquired Infections: Worth a Deeper Look.

Wright S, Doron S, Sarnak MJ.

Am J Kidney Dis. 2019 Jan;73(1):1-3. doi: 10.1053/j.ajkd.2018.08.019. Epub 2018 Nov 10. No abstract available.

PMID:
30424916
23.

Blood pressure target for the dialysis patient.

McCallum W, Sarnak MJ.

Semin Dial. 2019 Jan;32(1):35-40. doi: 10.1111/sdi.12754. Epub 2018 Nov 13. Review.

PMID:
30422343
24.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
26.

Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.

Ku E, Ix JH, Jamerson K, Tangri N, Lin F, Gassman J, Smogorzewski M, Sarnak MJ.

J Am Soc Nephrol. 2018 Sep;29(9):2401-2408. doi: 10.1681/ASN.2018040365. Epub 2018 Jul 13.

27.

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.

Selamet U, Katz R, Ginsberg C, Rifkin DE, Fried LF, Kritchevsky SB, Hoofnagle AN, Bibbins-Domingo K, Drew D, Harris T, Newman A, Gutiérrez OM, Sarnak MJ, Shlipak MG, Ix JH.

Am J Kidney Dis. 2018 Sep;72(3):419-428. doi: 10.1053/j.ajkd.2018.03.026. Epub 2018 Jun 6.

28.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, Tin A, Appel LJ, Chen J, Sarnak MJ, Grams ME.

Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.

29.

Intensive Blood Pressure Targets and Kidney Disease.

Chang TI, Sarnak MJ.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1575-1577. doi: 10.2215/CJN.02010218. Epub 2018 May 24. No abstract available.

30.

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME.

J Am Soc Nephrol. 2018 Jul;29(7):1939-1947. doi: 10.1681/ASN.2017101064. Epub 2018 May 18.

31.

Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Moorthi RN, Doshi S, Fried LF, Moe SM, Sarnak MJ, Satterfield S, Schwartz AV, Shlipak M, Lange-Maia BS, Harris TB, Newman AB, Strotmeyer ES.

Nephrol Dial Transplant. 2019 Apr 1;34(4):625-632. doi: 10.1093/ndt/gfy102.

32.

Low thyroid function is not associated with an accelerated deterioration in renal function.

Meuwese CL, van Diepen M, Cappola AR, Sarnak MJ, Shlipak MG, Bauer DC, Fried LP, Iacoviello M, Vaes B, Degryse J, Khaw KT, Luben RN, Åsvold BO, Bjøro T, Vatten LJ, de Craen AJM, Trompet S, Iervasi G, Molinaro S, Ceresini G, Ferrucci L, Dullaart RPF, Bakker SJL, Jukema JW, Kearney PM, Stott DJ, Peeters RP, Franco OH, Völzke H, Walsh JP, Bremner A, Sgarbi JA, Maciel RMB, Imaizumi M, Ohishi W, Dekker FW, Rodondi N, Gussekloo J, den Elzen WPJ; Thyroid Studies Collaboration.

Nephrol Dial Transplant. 2019 Apr 1;34(4):650-659. doi: 10.1093/ndt/gfy071.

33.

Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.

Drew DA, Katz R, Kritchevsky S, Ix JH, Shlipak MG, Newman AB, Hoofnagle A, Fried L, Sarnak MJ, Gutierrez OM.

Am J Nephrol. 2018;47(4):242-250. doi: 10.1159/000488361. Epub 2018 Apr 5.

34.

Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.

Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, Cummings SR, Sarnak MJ, Shlipak MG.

Am J Kidney Dis. 2018 Aug;72(2):205-213. doi: 10.1053/j.ajkd.2017.12.013. Epub 2018 Mar 27.

35.

Serum albumin concentration and risk of end-stage renal disease: the REGARDS study.

Walther CP, Gutiérrez OM, Cushman M, Judd SE, Lang J, McClellan W, Muntner P, Sarnak MJ, Shlipak MG, Warnock DG, Katz R, Ix JH.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1770-1777. doi: 10.1093/ndt/gfx331.

PMID:
29281114
36.

Relationship of acid-base status with arterial stiffness in community-living elders: the Health ABC Study.

Chen W, Newman AB, Fried LF, Rifkin DE, Shlipak MG, Sarnak MJ, Katz R, Madero M, Raphael KL, Bushinsky DA, Ix JH.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1572-1579. doi: 10.1093/ndt/gfx292.

37.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

38.

Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management.

Gupta A, Thomas TS, Klein JA, Montgomery RN, Mahnken JD, Johnson DK, Drew DA, Sarnak MJ, Burns JM.

Nephron. 2018;138(1):22-28. doi: 10.1159/000481182. Epub 2017 Oct 20.

39.

Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.

Lang J, Katz R, Ix JH, Gutierrez OM, Peralta CA, Parikh CR, Satterfield S, Petrovic S, Devarajan P, Bennett M, Fried LF, Cummings SR, Sarnak MJ, Shlipak MG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):986-992. doi: 10.1093/ndt/gfx229.

40.

Metabolomic Alterations Associated with Cause of CKD.

Grams ME, Tin A, Rebholz CM, Shafi T, Köttgen A, Perrone RD, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1787-1794. doi: 10.2215/CJN.02560317. Epub 2017 Sep 28.

41.

Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.

Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H.

Am J Kidney Dis. 2017 Dec;70(6):859-868. doi: 10.1053/j.ajkd.2017.08.003. Epub 2017 Sep 21. Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578-579.

PMID:
28941763
42.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

43.

White matter damage in maintenance hemodialysis patients: a diffusion tensor imaging study.

Drew DA, Koo BB, Bhadelia R, Weiner DE, Duncan S, la Garza MM, Gupta A, Tighiouart H, Scott T, Sarnak MJ.

BMC Nephrol. 2017 Jul 5;18(1):213. doi: 10.1186/s12882-017-0628-0.

44.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

45.

Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.

Sharma S, Sarnak MJ.

Nat Rev Nephrol. 2017 Aug;13(8):447-448. doi: 10.1038/nrneph.2017.84. Epub 2017 Jun 19. No abstract available.

PMID:
28626221
46.

Prevalence and correlates of cognitive impairment in kidney transplant recipients.

Gupta A, Mahnken JD, Johnson DK, Thomas TS, Subramaniam D, Polshak T, Gani I, John Chen G, Burns JM, Sarnak MJ.

BMC Nephrol. 2017 May 12;18(1):158. doi: 10.1186/s12882-017-0570-1.

47.

Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY.

J Am Soc Nephrol. 2017 Sep;28(9):2794-2801. doi: 10.1681/ASN.2017010040. Epub 2017 May 4.

48.

Association of Blood Pressure Trajectory With Mortality, Incident Cardiovascular Disease, and Heart Failure in the Cardiovascular Health Study.

Smitson CC, Scherzer R, Shlipak MG, Psaty BM, Newman AB, Sarnak MJ, Odden MC, Peralta CA.

Am J Hypertens. 2017 Jun 1;30(6):587-593. doi: 10.1093/ajh/hpx028.

49.

Association of urinary uromodulin with kidney function decline and mortality: the health ABC study
.

Garimella PS, Katz R, Ix JH, Fried LF, Kritchevsky SB, Devarajan P, Bennett MR, Parikh CR, Shlipak MG, Harris TB, Gutiérrez OM, Sarnak MJ.

Clin Nephrol. 2017 Jun;87(6):278-286. doi: 10.5414/CN109005.

50.

The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals.

Hughes-Austin JM, Rifkin DE, Beben T, Katz R, Sarnak MJ, Deo R, Hoofnagle AN, Homma S, Siscovick DS, Sotoodehnia N, Psaty BM, de Boer IH, Kestenbaum B, Shlipak MG, Ix JH.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):245-252. doi: 10.2215/CJN.06290616. Epub 2017 Jan 31.

Supplemental Content

Loading ...
Support Center